{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:10:09Z","timestamp":1790914209216,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bmcl.2025.130501","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T23:56:05Z","timestamp":1765238165000},"page":"130501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of flavonoid-based small molecule inhibitors with dual-targeting capability against RdRp and Mpro of SARS-CoV-2"],"prefix":"10.1016","volume":"132","author":[{"given":"Yanlei","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7811","key":"10.1016\/j.bmcl.2025.130501_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130501_bb0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130501_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130501_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design","volume":"23","author":"Malone","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130501_bb0025","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.medj.2023.08.001","article-title":"Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2","volume":"4","author":"Hirotsu","year":"2023","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130501_bb0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/ciac769","article-title":"Remdesivir resistance in transplant recipients with persistent coronavirus disease 2019","volume":"76","author":"Hogan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130501_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105501","article-title":"Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2","volume":"210","author":"Shannon","year":"2023","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130501_bb0040","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1186\/s12879-023-08797-6","article-title":"Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study","volume":"23","author":"Shimazu","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130501_bb0045","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"7982","key":"10.1016\/j.bmcl.2025.130501_bb0050","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41586-023-06609-0","article-title":"Molecular mechanisms of SARS-CoV-2 resistance to PF07321332","volume":"622","author":"Duan","year":"2023","journal-title":"Nature"},{"issue":"7987","key":"10.1016\/j.bmcl.2025.130501_bb0055","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-023-06649-6","article-title":"A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes","volume":"623","author":"Sanderson","year":"2023","journal-title":"Nature"},{"issue":"05","key":"10.1016\/j.bmcl.2025.130501_bb0060","first-page":"7","article-title":"Screening of anti-2019-nCoV inhibitors with the target of RNA-dependent RNA polymerase","volume":"38","author":"Su","year":"2020","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"04","key":"10.1016\/j.bmcl.2025.130501_bb0065","first-page":"94","article-title":"Fine analysis of the binding mode between traditional Chinese chemical components and 2019-nCoV RNA polymerase based on molecular docking technology","volume":"39","author":"Peng","year":"2021","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130501_bb0070","first-page":"20","article-title":"A Preliminary study on the effect of isoflavones against omicron strain","volume":"40","author":"Chang","year":"2022","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"01","key":"10.1016\/j.bmcl.2025.130501_bb0075","first-page":"18","article-title":"A preliminary study on the pharmacological activity of flavonoid monomers against omicron strain","volume":"41","author":"Wang","year":"2023","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"07","key":"10.1016\/j.bmcl.2025.130501_bb0080","first-page":"26","article-title":"Preliminary study on the activity of cynaroside against omicron subvariant","volume":"41","author":"Wang","year":"2023","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"08","key":"10.1016\/j.bmcl.2025.130501_bb0085","first-page":"14","article-title":"Preliminary study on the activity of baicalin against omicron subvariant BA.2.2","volume":"40","author":"Su","year":"2022","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"04","key":"10.1016\/j.bmcl.2025.130501_bb0090","first-page":"13","article-title":"A study on inhibition of SARS-CoV-2 main protease by flavonoids","volume":"41","author":"Wang","year":"2023","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130501_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051170","article-title":"Natural polyphenols, 1,2,3,4,6-O-pentagalloyglucose and proanthocyanidins, as broad-spectrum anticoronaviral inhibitors targeting Mpro and RdRp of SARS-CoV-2","volume":"10","author":"Jin","year":"2022","journal-title":"Biomedicines"},{"issue":"6489","key":"10.1016\/j.bmcl.2025.130501_bb0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130501_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41418-021-00900-1","article-title":"The NSP14\/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target","volume":"29","author":"Rona","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bmcl.2025.130501_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130501_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/v14071413","article-title":"Identifying structural features of nucleotide analogues to overcome SARS-CoV-2 exonuclease activity","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130501_bb0120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106379119","article-title":"Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN","volume":"119","author":"Moeller","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmcl.2025.130501_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114317","article-title":"Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2","volume":"299","author":"Schirtzinger","year":"2022","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130501_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13578-021-00720-3","article-title":"Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors","volume":"11","author":"Yan","year":"2021","journal-title":"Cell Biosci"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130501_bb0135","first-page":"9","article-title":"A study on inhibition of SARS-CoV-2 main protease by morusin","volume":"41","author":"Zhang","year":"2023","journal-title":"Chinese Arch Trad Chinese Med"},{"issue":"43","key":"10.1016\/j.bmcl.2025.130501_bb0140","article-title":"Miniaturized modular click chemistry-enabled rapid discovery of unique SARS-CoV-2 M(pro) inhibitors with robust potency and drug-like profile","volume":"11","author":"Yang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"7944","key":"10.1016\/j.bmcl.2025.130501_bb0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to PF07321332","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130501_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9050893","article-title":"Baicalein and baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase","volume":"9","author":"Zandi","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.bmcl.2025.130501_bb0155","unstructured":"Di K, Xie X, Zhao T, et al. Experimental study on the inhibitory activity of phloretin against SARS-CoV-2 RNA polymerase and activity prediction of its analogues. Chinese Arch Trad Chinese Med. 1-7."},{"issue":"15","key":"10.1016\/j.bmcl.2025.130501_bb0160","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1080\/07391102.2021.1897679","article-title":"Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study","volume":"40","author":"Gogoi","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2025.130501_bb0165","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760200207","article-title":"Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)","volume":"115","author":"da Silva","year":"2020","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bmcl.2025.130501_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105468","article-title":"Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: a promising therapeutic approach for Tackling COVID-19","volume":"145","author":"Parihar","year":"2022","journal-title":"Comput Biol Med"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130501_bb0175","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciad494","article-title":"PF07321332 Resistance-de Novo E166V\/L50V mutations in an immunocompromised patient treated with prolonged PF07321332\/ritonavir monotherapy leading to clinical and virological treatment failure-a case report","volume":"78","author":"Zuckerman","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130501_bb0180","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35431","article-title":"Emerging SARS-CoV-2 resistance after antiviral treatment","volume":"7","author":"Tamura","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130501_bb0185","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1038\/s41467-024-51924-3","article-title":"Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections","volume":"15","author":"Nooruzzaman","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130501_bb0190","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3201\/eid3006.240023","article-title":"Sporadic occurrence of ensitrelvir-resistant SARS-CoV-2, Japan","volume":"30","author":"Doi","year":"2024","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130501_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00840-23","article-title":"Evaluation of in vitro antiviral activity of SARS-CoV-2 M(pro) inhibitor pomotrelvir and cross-resistance to PF07321332 resistance substitutions","volume":"67","author":"Tong","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130501_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/v15091970","article-title":"Substitutions in SARS-CoV-2 Mpro selected by protease inhibitor boceprevir confer resistance to PF07321332","volume":"15","author":"Gammeltoft","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2025.130501_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106022","article-title":"Replication capacity and susceptibility of PF07321332-resistant mutants to next-generation Mpro inhibitors in a SARS-CoV-2 replicon system","volume":"231","author":"Lo","year":"2024","journal-title":"Antiviral Res"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500410X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500410X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:00:47Z","timestamp":1769835647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2500410X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S0960894X2500410X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130501","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of flavonoid-based small molecule inhibitors with dual-targeting capability against RdRp and Mpro of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130501"}}